This inventor holds 7 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Genentech, Inc., Recursion Pharmaceuticals, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Pioneering Cancer Treatment: Inventor Marie Evangelista
Introduction: Hailing from San Francisco, CA, inventor Marie Evangelista is making waves in the field of oncology with her groundbreaking patent on combination therapies for treating solid tumors.
Latest Patents: Marie Evangelista holds a notable patent for "Methods and compositions comprising a KRasinhibitor and a VEGF inhibitor for treating solid tumors." This patent showcases her innovative approach to combating cancer and highlights her expertise in developing effective treatment methods.
Career Highlights: Marie Evangelista is a key figure at Genentech, Inc., where she plays a pivotal role in research and development. Her dedication to advancing cancer treatment technologies has earned her recognition within the industry.
Collaborations: Working alongside colleagues such as Mark Andrew Merchant and Jennifer Lee Schutzman, Marie Evangelista thrives in collaborative environments. Together, they push the boundaries of science and strive to improve patient outcomes through innovative therapies.
Conclusion: Marie Evangelista's contributions to the field of oncology are invaluable, and her patent represents a significant step forward in the fight against solid tumors. With a passion for innovation and a drive to make a difference, Marie Evangelista continues to inspire others in the quest for better cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile